annual EBITDA:
$19.93B+$3.29B(+19.76%)Summary
- As of today (April 12, 2025), NVO annual EBITDA is $19.93 billion, with the most recent change of +$3.29 billion (+19.76%) on December 31, 2024.
- During the last 3 years, NVO annual EBITDA has risen by +$9.53 billion (+91.55%).
- NVO annual EBITDA is now at all-time high.
Performance
NVO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$5.74B+$230.71M(+4.19%)Summary
- As of today (April 12, 2025), NVO quarterly EBITDA is $5.74 billion, with the most recent change of +$230.71 million (+4.19%) on December 31, 2024.
- Over the past year, NVO quarterly EBITDA has stayed the same.
- NVO quarterly EBITDA is now at all-time high.
Performance
NVO quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$21.78B+$1.62B(+8.04%)Summary
- As of today (April 12, 2025), NVO TTM EBITDA is $21.78 billion, with the most recent change of +$1.62 billion (+8.04%) on December 31, 2024.
- Over the past year, NVO TTM EBITDA has stayed the same.
- NVO TTM EBITDA is now at all-time high.
Performance
NVO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NVO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.8% | 0.0% | 0.0% |
| 3 y3 years | +91.5% | +170.1% | +109.2% |
| 5 y5 years | +144.2% | +306.6% | +158.8% |
NVO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.5% | at high | +304.5% | at high | +104.6% |
| 5 y | 5-year | at high | +144.2% | at high | +304.5% | at high | +158.8% |
| alltime | all time | at high | >+9999.0% | at high | +412.6% | at high | +3027.6% |
Novo Nordisk A/S EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $19.93B(+19.8%) | $5.74B(+4.2%) | $21.78B(+8.0%) |
| Sep 2024 | - | $5.51B(+6.7%) | $20.15B(+3.7%) |
| Jun 2024 | - | $5.16B(-4.0%) | $19.43B(+6.9%) |
| Mar 2024 | - | $5.38B(+30.6%) | $18.18B(+8.3%) |
| Dec 2023 | $16.64B(+52.9%) | $4.11B(-14.0%) | $16.78B(+19.2%) |
| Sep 2023 | - | $4.78B(+22.5%) | $14.08B(+12.5%) |
| Jun 2023 | - | $3.90B(-1.8%) | $12.52B(+6.8%) |
| Mar 2023 | - | $3.98B(+180.5%) | $11.72B(+7.4%) |
| Dec 2022 | $10.89B(+4.6%) | $1.42B(-56.0%) | $10.91B(-6.1%) |
| Sep 2022 | - | $3.22B(+3.8%) | $11.62B(+4.2%) |
| Jun 2022 | - | $3.10B(-2.0%) | $11.15B(+4.8%) |
| Mar 2022 | - | $3.17B(+49.2%) | $10.64B(+2.2%) |
| Dec 2021 | $10.41B(+14.6%) | $2.12B(-23.0%) | $10.41B(+2.5%) |
| Sep 2021 | - | $2.76B(+6.3%) | $10.16B(+3.9%) |
| Jun 2021 | - | $2.59B(-11.7%) | $9.77B(+3.9%) |
| Mar 2021 | - | $2.94B(+57.0%) | $9.41B(+4.1%) |
| Dec 2020 | $9.08B(+11.3%) | $1.87B(-21.2%) | $9.04B(+5.4%) |
| Sep 2020 | - | $2.37B(+6.4%) | $8.58B(+1.6%) |
| Jun 2020 | - | $2.23B(-13.3%) | $8.45B(+0.4%) |
| Mar 2020 | - | $2.57B(+82.1%) | $8.41B(+2.9%) |
| Dec 2019 | $8.16B(-0.2%) | $1.41B(-37.0%) | $8.17B(-2.7%) |
| Sep 2019 | - | $2.24B(+2.1%) | $8.40B(+3.4%) |
| Jun 2019 | - | $2.19B(-5.9%) | $8.13B(-0.6%) |
| Mar 2019 | - | $2.33B(+42.2%) | $8.18B(-0.5%) |
| Dec 2018 | $8.18B(+3.4%) | $1.64B(-16.6%) | $8.22B(+1.3%) |
| Sep 2018 | - | $1.96B(-12.5%) | $8.11B(-0.6%) |
| Jun 2018 | - | $2.25B(-5.4%) | $8.16B(+0.9%) |
| Mar 2018 | - | $2.37B(+54.8%) | $8.09B(+3.9%) |
| Dec 2017 | $7.91B(+4.2%) | $1.53B(-24.0%) | $7.79B(-2.0%) |
| Sep 2017 | - | $2.01B(-7.1%) | $7.94B(+0.5%) |
| Jun 2017 | - | $2.17B(+4.7%) | $7.90B(+2.1%) |
| Mar 2017 | - | $2.07B(+22.7%) | $7.74B(+2.0%) |
| Dec 2016 | $7.59B(+9.7%) | $1.69B(-14.4%) | $7.58B(+11.5%) |
| Sep 2016 | - | $1.97B(-1.7%) | $6.80B(+1.4%) |
| Jun 2016 | - | $2.01B(+4.7%) | $6.71B(+0.9%) |
| Mar 2016 | - | $1.92B(+111.4%) | $6.65B(-4.7%) |
| Dec 2015 | $6.92B(+3.3%) | $906.12M(-51.8%) | $6.97B(-6.8%) |
| Sep 2015 | - | $1.88B(-3.3%) | $7.48B(+1.2%) |
| Jun 2015 | - | $1.94B(-13.3%) | $7.39B(+2.0%) |
| Mar 2015 | - | $2.24B(+58.7%) | $7.25B(+8.0%) |
| Dec 2014 | $6.70B(+6.3%) | $1.41B(-21.2%) | $6.71B(+1.1%) |
| Sep 2014 | - | $1.79B(-0.5%) | $6.64B(+4.7%) |
| Jun 2014 | - | $1.80B(+5.7%) | $6.34B(+3.8%) |
| Mar 2014 | - | $1.70B(+26.8%) | $6.11B(+5.3%) |
| Dec 2013 | $6.30B(+19.4%) | $1.34B(-10.2%) | $5.80B(+5.9%) |
| Sep 2013 | - | $1.49B(-4.7%) | $5.47B(+3.3%) |
| Jun 2013 | - | $1.57B(+12.4%) | $5.30B(+4.3%) |
| Mar 2013 | - | $1.39B(+36.8%) | $5.08B(+5.4%) |
| Dec 2012 | $5.28B(+13.3%) | $1.02B(-22.8%) | $4.82B(+0.9%) |
| Sep 2012 | - | $1.32B(-2.0%) | $4.78B(+5.0%) |
| Jun 2012 | - | $1.35B(+18.7%) | $4.55B(+6.5%) |
| Mar 2012 | - | $1.13B(+16.0%) | $4.27B(+3.0%) |
| Dec 2011 | $4.66B(+23.1%) | $977.58M(-10.6%) | $4.15B(+3.3%) |
| Sep 2011 | - | $1.09B(+2.4%) | $4.02B(+2.5%) |
| Jun 2011 | - | $1.07B(+5.8%) | $3.92B(+2.1%) |
| Mar 2011 | - | $1.01B(+19.4%) | $3.84B(+1.7%) |
| Dec 2010 | $3.78B(+13.6%) | $845.28M(-15.1%) | $3.77B(+1.2%) |
| Sep 2010 | - | $995.03M(+0.8%) | $3.73B(+3.8%) |
| Jun 2010 | - | $987.10M(+4.2%) | $3.59B(+3.2%) |
| Mar 2010 | - | $947.01M(+18.5%) | $3.48B(+4.6%) |
| Dec 2009 | $3.33B(+13.8%) | $799.48M(-7.0%) | $3.33B(+13.2%) |
| Sep 2009 | - | $859.22M(-1.7%) | $2.94B(+5.0%) |
| Jun 2009 | - | $874.32M(+10.3%) | $2.80B(+11.0%) |
| Mar 2009 | - | $792.80M(+92.6%) | $2.52B(+6.0%) |
| Dec 2008 | $2.93B(+33.0%) | $411.63M(-42.7%) | $2.38B(+8.6%) |
| Sep 2008 | - | $718.81M(+20.5%) | $2.19B(+11.4%) |
| Jun 2008 | - | $596.69M(-8.3%) | $1.97B(+4.7%) |
| Mar 2008 | - | $650.48M(+190.8%) | $1.88B(+14.8%) |
| Dec 2007 | $2.20B(+16.1%) | $223.68M(-54.8%) | $1.64B(-7.9%) |
| Sep 2007 | - | $494.88M(-2.7%) | $1.78B(+4.0%) |
| Jun 2007 | - | $508.61M(+24.6%) | $1.71B(+3.9%) |
| Mar 2007 | - | $408.19M(+12.2%) | $1.64B(+1.8%) |
| Dec 2006 | $1.90B(+13.5%) | $363.90M(-14.8%) | $1.61B(+3.8%) |
| Sep 2006 | - | $426.95M(-3.8%) | $1.56B(+3.3%) |
| Jun 2006 | - | $443.88M(+17.1%) | $1.51B(+3.3%) |
| Mar 2006 | - | $379.07M(+24.2%) | $1.46B(+8.4%) |
| Dec 2005 | $1.67B(+11.8%) | $305.28M(-19.1%) | $1.35B(-2.2%) |
| Sep 2005 | - | $377.50M(-4.8%) | $1.38B(+7.1%) |
| Jun 2005 | - | $396.48M(+48.8%) | $1.29B(+7.6%) |
| Mar 2005 | - | $266.44M(-20.6%) | $1.19B(+1.1%) |
| Dec 2004 | $1.49B | $335.65M(+17.2%) | $1.18B(-258.8%) |
| Sep 2004 | - | $286.45M(-6.4%) | -$743.79M(+327.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $305.95M(+20.8%) | -$174.15M(-148.5%) |
| Mar 2004 | - | $253.37M(-115.9%) | $358.96M(-57.5%) |
| Dec 2003 | $1.22B(+31.4%) | -$1.59B(-285.7%) | $844.54M(+12.6%) |
| Sep 2003 | - | $856.09M(+2.0%) | $750.05M(+0.3%) |
| Jun 2003 | - | $839.06M(+13.5%) | $747.75M(+33.1%) |
| Mar 2003 | - | $738.95M(-143.9%) | $561.66M(+5.4%) |
| Dec 2002 | $929.48M(+15.9%) | -$1.68B(-297.2%) | $532.93M(-35.0%) |
| Sep 2002 | - | $853.80M(+30.8%) | $820.23M(+7.5%) |
| Jun 2002 | - | $652.97M(-8.1%) | $763.23M(-2.5%) |
| Mar 2002 | - | $710.22M(-150.8%) | $782.93M(+6.6%) |
| Dec 2001 | $802.21M(+22.6%) | -$1.40B(-275.3%) | $734.28M(+64.1%) |
| Sep 2001 | - | $796.80M(+18.5%) | $447.56M(-70.4%) |
| Jun 2001 | - | $672.68M(+1.7%) | $1.51B(-8.4%) |
| Mar 2001 | - | $661.56M(-139.3%) | $1.65B(-4.4%) |
| Dec 2000 | $654.19M(+18.0%) | -$1.68B(-190.4%) | $1.73B(+3.2%) |
| Sep 2000 | - | $1.86B(+129.8%) | $1.67B(+164.8%) |
| Jun 2000 | - | $810.58M(+9.9%) | $631.91M(+18.0%) |
| Mar 2000 | - | $737.25M(-142.4%) | $535.67M(+7.6%) |
| Dec 1999 | $554.52M(+53.3%) | -$1.74B(-311.5%) | $497.68M(+24.2%) |
| Sep 1999 | - | $821.66M(+15.0%) | $400.56M(+21.5%) |
| Jun 1999 | - | $714.35M(+2.2%) | $329.62M(+16.3%) |
| Mar 1999 | - | $699.25M(-138.1%) | $283.42M(+49.8%) |
| Dec 1998 | $361.73M(-31.4%) | -$1.83B(-344.4%) | $189.17M(-64.5%) |
| Sep 1998 | - | $750.72M(+12.4%) | $533.53M(+30.1%) |
| Jun 1998 | - | $668.15M(+10.4%) | $410.22M(+9.7%) |
| Mar 1998 | - | $605.00M(-140.6%) | $373.83M(+8.7%) |
| Dec 1997 | $527.21M(+0.3%) | -$1.49B(-337.5%) | $343.90M(-1.1%) |
| Sep 1997 | - | $627.41M(-0.7%) | $347.59M(-2.2%) |
| Jun 1997 | - | $631.76M(+9.9%) | $355.50M(+10.7%) |
| Mar 1997 | - | $575.07M(-138.7%) | $321.20M(-8.5%) |
| Dec 1996 | $525.67M(-2.3%) | -$1.49B(-334.0%) | $351.00M(+13.0%) |
| Sep 1996 | - | $635.32M(+6.3%) | $310.67M(+22.2%) |
| Jun 1996 | - | $597.46M(-1.2%) | $254.25M(-17.8%) |
| Mar 1996 | - | $604.87M(-139.6%) | $309.26M(+10.6%) |
| Dec 1995 | $537.93M(+17.9%) | -$1.53B(-363.8%) | $279.55M(-39.6%) |
| Sep 1995 | - | $578.90M(-11.3%) | $462.93M(+7.2%) |
| Jun 1995 | - | $652.47M(+13.4%) | $431.98M(+41.5%) |
| Mar 1995 | - | $575.16M(-142.8%) | $305.32M(+57.9%) |
| Dec 1994 | $456.28M(+7.7%) | -$1.34B(-345.2%) | $193.31M(-61.2%) |
| Sep 1994 | - | $547.95M(+4.2%) | $498.12M(+20.1%) |
| Jun 1994 | - | $525.81M(+13.5%) | $414.84M(+11.2%) |
| Mar 1994 | - | $463.15M(-144.6%) | $373.05M(+13.9%) |
| Dec 1993 | $423.64M(+37.8%) | -$1.04B(-323.6%) | $327.44M(+42.2%) |
| Sep 1993 | - | $464.66M(-4.0%) | $230.21M(+4.7%) |
| Jun 1993 | - | $484.02M(+15.9%) | $219.90M(+17.9%) |
| Mar 1993 | - | $417.53M(-136.8%) | $186.47M(-3.2%) |
| Dec 1992 | $307.54M(-1.7%) | -$1.14B(-350.0%) | $192.69M(-58.0%) |
| Sep 1992 | - | $454.35M(+0.8%) | $458.91M(+27.5%) |
| Jun 1992 | - | $450.60M(+6.3%) | $359.94M(+45.3%) |
| Mar 1992 | - | $423.75M(-148.7%) | $247.65M(+17.7%) |
| Dec 1991 | $312.86M(+22.8%) | -$869.78M(-344.7%) | $210.43M(-4.3%) |
| Sep 1991 | - | $355.38M(+5.1%) | $219.95M(+10.7%) |
| Jun 1991 | - | $338.30M(-12.5%) | $198.62M(+11.5%) |
| Mar 1991 | - | $386.54M(-144.9%) | $178.09M(+99.9%) |
| Dec 1990 | $254.78M(+22.2%) | -$860.27M(-357.5%) | $89.08M(-72.2%) |
| Sep 1990 | - | $334.06M(+5.1%) | $320.60M(+45.5%) |
| Jun 1990 | - | $317.76M(+6.8%) | $220.29M(+61.6%) |
| Mar 1990 | - | $297.53M(-147.3%) | $136.35M(+19.6%) |
| Dec 1989 | $208.49M(+11.1%) | -$628.74M(-369.0%) | $113.96M(-61.5%) |
| Sep 1989 | - | $233.75M(-0.0%) | $295.66M(+19.7%) |
| Jun 1989 | - | $233.82M(-15.0%) | $247.03M(+9.3%) |
| Mar 1989 | - | $275.14M(-161.5%) | $226.03M(+66.2%) |
| Dec 1988 | $187.59M(+40.3%) | -$447.04M(-341.5%) | $136.02M(+8.2%) |
| Sep 1988 | - | $185.12M(-13.0%) | $125.67M(+3.7%) |
| Jun 1988 | - | $212.81M(+15.0%) | $121.19M(+51.2%) |
| Mar 1988 | - | $185.13M(-140.5%) | $80.13M(+12.1%) |
| Dec 1987 | $133.75M(+20.8%) | -$457.39M(-353.2%) | $71.49M(-64.6%) |
| Sep 1987 | - | $180.64M(+5.2%) | $202.13M(+34.0%) |
| Jun 1987 | - | $171.75M(-2.7%) | $150.89M(+33.6%) |
| Mar 1987 | - | $176.49M(-154.0%) | $112.91M(+105.3%) |
| Dec 1986 | $110.76M(+24.8%) | -$326.75M(-352.5%) | $55.00M(-56.7%) |
| Sep 1986 | - | $129.40M(-3.3%) | $126.97M(+35.8%) |
| Jun 1986 | - | $133.77M(+12.8%) | $93.51M(+70.1%) |
| Mar 1986 | - | $118.58M(-146.5%) | $54.98M(+90.2%) |
| Dec 1985 | $88.77M(+24.5%) | -$254.79M(-365.6%) | $28.90M(-65.6%) |
| Sep 1985 | - | $95.94M(+0.7%) | $83.91M(+5.5%) |
| Jun 1985 | - | $95.24M(+3.0%) | $79.51M(+5.4%) |
| Mar 1985 | - | $92.51M(-146.3%) | $75.44M(+0.5%) |
| Dec 1984 | $71.32M | -$199.77M(-318.2%) | $75.07M(-72.7%) |
| Sep 1984 | - | $91.54M(+0.4%) | $274.84M(+49.9%) |
| Jun 1984 | - | $91.16M(-1.1%) | $183.30M(+98.9%) |
| Mar 1984 | - | $92.14M | $92.14M |
FAQ
- What is Novo Nordisk A/S annual EBITDA?
- What is the all time high annual EBITDA for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual EBITDA year-on-year change?
- What is Novo Nordisk A/S quarterly EBITDA?
- What is the all time high quarterly EBITDA for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly EBITDA year-on-year change?
- What is Novo Nordisk A/S TTM EBITDA?
- What is the all time high TTM EBITDA for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM EBITDA year-on-year change?
What is Novo Nordisk A/S annual EBITDA?
The current annual EBITDA of NVO is $19.93B
What is the all time high annual EBITDA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual EBITDA is $19.93B
What is Novo Nordisk A/S annual EBITDA year-on-year change?
Over the past year, NVO annual EBITDA has changed by +$3.29B (+19.76%)
What is Novo Nordisk A/S quarterly EBITDA?
The current quarterly EBITDA of NVO is $5.74B
What is the all time high quarterly EBITDA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly EBITDA is $5.74B
What is Novo Nordisk A/S quarterly EBITDA year-on-year change?
Over the past year, NVO quarterly EBITDA has changed by $0.00 (0.00%)
What is Novo Nordisk A/S TTM EBITDA?
The current TTM EBITDA of NVO is $21.78B
What is the all time high TTM EBITDA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM EBITDA is $21.78B
What is Novo Nordisk A/S TTM EBITDA year-on-year change?
Over the past year, NVO TTM EBITDA has changed by $0.00 (0.00%)